CD248 and neoplasm: Importantly, CD248 is overexpressed specifically in tumor-associated fibroblasts and pericytes residing in tumor blood vessels, but is barely expressed in normal tissues (28, 29), making CD248 an oncofetal protein with potential as a biomarker and therapeutic target.